Contact
If you need media that scales, we'd like to help. Get in touch with us using the form below.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
If you need media that scales, we'd like to help. Get in touch with us using the form below.
Biopharma manufacturing is under constant pressure: accelerate timelines, reduce costs, and maintain strict quality standards. But when cell culture media isn’t designed for your cells, your objectives, and your constraints, the hidden waste adds up fast.
Learn more
Multus Food-Grade DMEM-F12 with sallea's ProteinPURE scaffolds supported significantly higher metabolic activity on day 0 compared to Pharmaceutical-Grade DMEM-F12, indicating enhanced initial attachment...
Learn more
MediOP™ is Multus’ AI-enabled media design platform. It powers every one of our off-the-shelf and custom formulations by turning media development into a data-rich engineering discipline to deliver faster cycles, tighter batch-to-batch consistency, clearer regulatory pathways, and media brings scale-up within reach.
Learn more
Proliferum B achieved 142% improved cell attachment and maintained 3x higher cell density compared to FBS controls, with consistent performance across multiple mycelial strains.
Learn more
Opo Bio evaluated Proliferum B with their proprietary bovine fibroblast and satellite (Opo-Moo) cell lines, benchmarking against serum-containing media in standard 6-well plates with vitronectin coating.
Learn more
Fishway and Multus Biotechnology have entered into a strategic partnership to develop scalable, cost-effective cultivated fish. The collaboration brings together Fishway’s expertise in fish cell line development and Multus’ AI-driven platform for optimising growth media, with both companies aiming to accelerate the availability of cultivated seafood.
Learn more
Product development in biomanufacturing is known for being slow and unpredictable. It typically takes years with suboptimal results. But the industry can’t afford to wait that long, especially when it comes to key upstream inputs like growth media, where slow timelines can bottleneck entire manufacturing pipelines.
Learn more
Multus Biotechnology has introduced Proliferum P, the first commercially available animal component-free (ACF) serum replacement formulated specifically for porcine adipose-derived stem cells (ASCs).
Learn more
At Multus, we’re fortunate to be guided by a world-class Scientific Advisory Board - experts who help us make high-impact decisions as we build the next generation of growth media.
Learn more
UK firm Multus Biotechnology has unveiled an animal-free media formulation for cultivated meat, allowing companies to eliminate serum from their products.
Learn more
Multus' newest serum replacement product, Proliferum® P, is the first commercially available animal component-free (ACF) media formulation for porcine adipose-derived stem cells, developed in under 6 months using AI-powered optimization.
Learn more
Advanced Therapy Medicinal Products (ATMPs) are pushing the boundaries of modern medicine. Examples such as CAR T therapies, stem cell treatments, and viral vector delivery systems are opening new doors for how we treat disease. But turning that potential into reality at scale is no easy task.
Learn more
Nexture Bio successfully replaced fetal bovine serum with Multus' Proliferum B to achieve animal-component-free cell attachment and viability on microcarriers in 3D suspension, enabling scalable, ethical cultivated meat production.
Learn more
Wildtype leveraged Proliferum B to overcome a key bottleneck in cultivated seafood production - achieving superior scaffold attachment and cell viability post-suspension without animal-derived components, paving the way for scalable, ethical, and regulation-friendly manufacturing.
Learn more
Multus Biotechnology, a leader in growth media solutions for the cultivated meat industry, is proud to announce the launch of its food-grade DMEM/F12 basal media – DMEM/F12-FG.
Learn more
As the cultivated meat industry works towards delivering sustainable, affordable meat alternatives, high cost and complexity of growth media remain some of the biggest hurdles.
Learn more
New Wave Biotech has partnered with Multus to optimise biomanufacturing processes, achieving a remarkable 55% reduction in production costs for cultivated meat applications.
Learn more
Cultivated meat promises to revolutionise the global food system. Despite its potential, the industry faces hurdles that continue to slow its progress towards commercial viability. Basal media is one of the most critical - and often overlooked - challenges.
Learn more
Cultivated meat is edging closer to becoming a commercial reality, but there are challenges still making it hard to manufacture at scale and reduce price. Basal media is a vital component in cultivated meat production, but traditional options are expensive...
Learn more
Access and download documentation for Proliferum products, basal media and ingredients.
Learn more
Cultivated meat has a growing audience - headlines are breaking into the mainstream, and the industry is beginning to attract non-scientists who want to work on food sustainability.Like any field, cultivated meat has its language, which can be confusing at best, even alienating and restrictive at times, as it can hinder communication...
Learn more
Multus has opened a world first media manufacturing facility to help scaling cultivated meat companies cut costs and accelerate from lab to market.
Learn more
Quest Meat and Multus are working together to create affordable and sustainable cultivated meat production technology that scales.
Learn more
Innovate UK-backed partnership harnesses AI to scale cultivated meat quicker, better and at lower cost
Learn more
Funded by Innovate UK, a new consortium between industry and academia will advance the development of global standards for food-safe growth media formulations and ingredients.
Learn more
We’ve spoken to over 60 cultivated meat companies around the world about their barriers to scaling. A common trend is efficient media sourcing.
Learn more
Partnering with a specialist in growth media can turn bottlenecks into breakthroughs that accelerate scale-up and de-risk the business
Learn more
We’ve collaborated with Extracellular to launch the first licence free cultivated meat cell bank and lower the barriers for cultivated meat R&D.
Learn more
Multus partners with Appleton Woods To Bring A New Range Of Advanced Serum Free Media Formulations And Ingredients To UK Life Sciences
Learn more.jpg)
This article digs into effective growth media ingredient selection and formulation design for the cultivated meat industry. Co-Authored by Cai Linton, CEO Multus and Will Milligan, CEO Extracellular
Learn more
The first in a series of articles from Will Milligan, CEO of Extracellular, and Cai Linton, CEO of Multus
Learn more%20-%20thumbnail.jpg)
We are excited to announce the close of a USD$9.5m Series A investment round. The funding includes an equity free grant of USD$2.5M from Innovate UK through Europe’s most competitive startup grant, the EIC Accelerator.
Learn more
Consumers, producers, and governments increasingly recognise the need to move away from animal products and the benefits of investing in alternative proteins.
Learn more
CEO Cai Linton was invited to Paris to speak about how we’re enabling the creation of pain-free meat by developing alternative culture media for lab-grown food at Novozymes Innovation Day in collaboration with Plug and Play Tech Center.
Learn more
We have reached the final of the Nutreco Feed and Food Tech Challenge! In October this year, we’ll be in Amsterdam, pitching in front of investors to show them how we can make the future of food more #sustainable and more #ethical.
Learn more
Read how Innovate UK EDGE support enabled us to develop a game changing IP strategy, become investment ready and secure new partnerships as a platform for job growth.
Learn more
CEO Cai Linton was in the Houses of Parliament for the launch of the Alternative Proteins Association to champion cultivated meat and call for its inclusion in the National Food Strategy
Learn moreWe are excited to announce that we raised £1.6M ($2.2M) as part of our latest fundraising. Investors include SOSV, Zero Carbon Capital, Marinya Capital and angel Sake Bosch, together with an equity-free grant of £106k from the UK Research and Innovation Council. Read our full press release here.
Learn more
We have joined the EIT Food Accelerator Network programme, a Europe-wide programme that connects us to impactful agritech and foodTech startups and industry-leading corporates to pilot our technology and achieve successful market adoption.
Learn more
We received equity-free funding from the UK government to progress our R&D in Q1 2021 towards a more sustainable green future despite the Covid-19 pandemic.
Learn more
Sorry, no results...
